Cited by 106Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum

Open access
Donovan, Nancy J., Wadsworth, Lauren P., Lorius, Natacha, Locascio, Joseph J., Rentz, Dorene M., Johnson, Keith A., Sperling, Reisa A., Marshall, Gad A.·2014·The American Journal of Geriatric Psychiatry

Abstract

Objectives To examine regions of cortical thinning and cerebrospinal fluid (CSF) Alzheimer disease (AD) biomarkers associated with apathy and hallucinations in a continuum of individuals including clinically normal elderly, mild cognitive impairment, and mild AD dementia.Design Cross-sectional and longitudinal studies.Setting Fifty-seven research sites across North America.Participants Eight-hundred twelve community-dwelling volunteers; 413 participants in the CSF sub-study.Measurements Structural magnetic resonance imaging data and CSF concentrations of amyloid-β 1-42, total tau, and phosphorylated tau derived from the Alzheimer Disease Neuroimaging Initiative database were analyzed. Apathy and hallucinations were measured at baseline and over 3 years using the Neuropsychiatric Inventory-Questionnaire. General linear models and mixed effects models were used to evaluate the relationships among baseline cortical thickness in seven regions, and baseline CSF biomarkers, apathy, and hallucinations at baseline and longitudinally. Covariates included diagnosis, sex, age, apolipoprotein E genotype, premorbid intelligence, memory performance, processing speed, antidepressant use, and AD duration.Results Reduced baseline inferior temporal cortical thickness was predictive of increasing apathy over time, and reduced supramarginal cortical thickness was predictive of increasing hallucinations over time. There was no association with cortical thickness at baseline. CSF biomarkers were not related to severity of apathy or hallucinations in cross-sectional or longitudinal analyses.Conclusions These results suggest that greater baseline temporal and parietal atrophy is associated with worsening apathy and hallucinations in a large AD spectrum cohort, while adjusting for multiple disease-related variables. Localized cortical neurodegeneration may contribute to the pathophysiology of apathy and hallucinations and their adverse consequences in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jagp.2013.03.006

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Donovan, N. J., Wadsworth, L. P., Lorius, N., Locascio, J. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
Corresponding author
Donovan, Nancy J.
Venue
The American Journal of Geriatric Psychiatry
Publisher
Elsevier BV
Published
2014-11
Volume
22
Issue
11
Pages
1168-1179
ISSN
1064-7481 (ISSN-L)
OpenAlex
W2086731062
Cited by
106
References
44
Citations by year
2026: 4 · 2025: 9 · 2024: 8 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 5 · 2017: 11 · 2016: 8 · 2015: 9 · 2014: 6
FWCI
5.43
Type
journal article
Language
en
Open access
Locations
  • American Journal of Geriatric Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • NIH grant (U01 AG024904)
  • National Institute on Aging
  • National Institute of Biomedical Imaging and Bioengineering
  • Rosalinde and Arthur Gilbert Foundation/AFAR New Investigator Awards in Alzheimer's disease (R01 AG027435, K23 AG033634, K24 AG035007, D01 HP08794-04-00)
  • Massachusetts Alzheimer's Disease Research Center (P50 AG005134)
  • Harvard Aging Brain Study (P01 AGO36694)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
Alzheimer's disease, cortical thinning, apathy, hallucinations, inferior temporal cortex, supramarginal cortex, cerebrospinal fluid biomarkers, amyloid-beta 42, tau protein, mild cognitive impairment, dementia, neurodegeneration, neuropsychiatric symptoms
MeSH terms
Aged, Alzheimer Disease, Cerebral Cortex, Cross-Sectional Studies, Female, Hallucinations, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Peptide Fragments, Biomarkers, Amyloid beta-Peptides, tau Proteins, Apathy, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review